Bio-Rad Laboratories, Inc. is a global provider of life science research and clinical diagnostic products. The company operates through two primary business segments: Life Science and Clinical Diagnostics. Within the Life Science segment, Bio-Rad offers instruments, reagents and consumables for protein analysis, cell biology, gene expression and other molecular biology applications. The Clinical Diagnostics segment supplies quality control products, blood-typing reagents and instruments, and molecular diagnostic assays used in blood screening, infectious disease testing and routine clinical laboratories.
Founded in 1952 by David and Alice Schwartz and headquartered in Hercules, California, Bio-Rad has grown its footprint across the Americas, Europe, Asia-Pacific and other regions. Its life science tools support academic and pharmaceutical research, while its diagnostics solutions serve hospitals, reference laboratories and blood banks worldwide. The company places particular emphasis on product reliability, regulatory compliance and technical support for its diverse customer base.
Over its history, Bio-Rad has expanded through both internal development and strategic acquisitions, broadening its portfolio with products such as electrophoresis systems, imaging platforms, droplet digital PCR and automated blood-typing instruments. The firm is led by Norman Schwartz, who serves as chairman and chief executive officer, building on the legacy of its founders. Through continued investment in research and development, Bio-Rad aims to deliver innovative technologies that address evolving challenges in life science research and clinical diagnostics.
AI Generated. May Contain Errors.